| INTRODUC TI ON
OLT is lifesaving for patients with end stage liver disease. Complications can occur at any moment but are most common in the first postoperative weeks. Some of the most feared complication is the vascular complications, such as bleeding, stenosis, and thrombosis. They can arise from any of the vascular anastomoses created during surgery and are especially feared in pediatric OLT's as they can have immediate and devastating effects on both patient-and graft survival. [1] [2] [3] US with Doppler capability is usually the primary imaging technique used by the radiologist for identification of vascular complications-particularly in the early postoperative period due to its portable, fast, non-radioactive, and non-invasive nature. It can be used to reveal the parenchymal appearance of the liver graft, the structure of blood vessels and perihepatic conditions. Additionally, Doppler ultrasound can evaluate the hemodynamics including patency, direction, and velocity of the blood flow. [4] [5] [6] The diagnostic capabilities of US can be further expanded using an i.v administered microbubble contrast agent. In the post-liver transplant setting, CEUS can be used to assess microcirculation and perfusion of the liver graft and facilitates visualization of blood vessels, providing real-time angiographic-like images with high diagnostic accuracy. 4, [7] [8] [9] [10] In the adult population, official guidelines and recommendations have been issued for the use of CEUS after transplantation. 11 However, sulfur hexafluoride, is except for recently in the US, 12 not licensed for use in children, 13 and therefore, it is used off-label.
Nevertheless, as in the adult population, recommendations for the pediatric population are in fact in place. 14 A recently published review concludes that CEUS can confidently detect important postoperative complications in the pediatric liver transplantation population. 15 In our institution, it is standard protocol to have a radiologist to perform a bedside Doppler ultrasound within the first 24 postoperative hours. Doppler ultrasound is also the modality of choice when it comes to the outpatient standard follow-up examinations.
Sulfur hexafluoride microbubbles are administered, and a CEUS is performed at the discretion of the radiologist.
This retrospective study was conducted to outline our experience regarding the circulatory evaluation of pediatric patients postliver transplantation using sulfur hexafluoride CEUS. Data regarding patient weight, height, and administered contrast dose were also collected. Sulfur hexafluoride is delivered in 5 mL vials and the recommended standard dose for adults is 2.4 mL. The standard dosage for pediatric patients in our institution is to administer 0.1 mL/kg body weight, up to 24 kg. Patients weighing 24 kg or more are given the full dose of 2.4 mL. When needed, repeated doses were given.
| MATERIAL S AND ME THODS
Electronic patient charts were used to verify the indication for the examination, the outcome of the examination, and any action taken in response to that outcome.
For calculation of the PPV, our reference was the transplant surgeon's diagnosis per-operatively since all clinically significant true positive findings result in emergency surgery after the examination.
The patient not needing surgery for vascular complications within 30 days from the transplantation served as the reference for calculating the NPV.
The institutional review board approved this study. (Table 1) .
| RE SULTS
BA was the most common cause for transplantation. The relative frequency of the different pretransplant diagnoses ( Figure 1 ) was in proportion with current statistics from the ELTR. 16 As seen in Table 2 , three of 37 patients (8%) in the "cholestatic condition" group had either an arterial or a portal vein problem. The same was true for one patient (3%) in the "other" group.
The total arterial and portal venous complication rate was 11% (4/37) and 5% (2/37), respectively. Two of the arterial complications were attributed to HAT which represented 5% (2/37). One of the venous complications was due to PVT which represented 3% (1/37). Initially, one additional case of arterial complication and one case of portal venous complication were reported on CEUS, but both were considered false positives (see cases 5 & 6 in "Case descriptions").
| Case descriptions
Four patients had no hepatic arterial circulation. Of these, two also lacked portal vein circulation. Another patient was reported to have no arterial circulation on CEUS but turned out to be a false positive. Furthermore, one patient was reported to have reduced portal vein circulation. This case also turned out to be a false positive. Here we present a short description of the specific circumstances around each of these six patients.
| Case 1
A 9-year-old girl with hepatopulmonary syndrome related to AdamsOliver syndrome in stable condition preoperatively who received a whole liver from a DD. During surgery, the hepatic artery was spastic and arterial flow severely reduced. Portal flow was normal. On the 1st postoperative day, the routinely performed CEUS reported absent arterial as well as portal vein circulation. The patient went to emergency surgery where the diagnosis of HAT and PVT was confirmed. However, the circulation could not be restored and a transplantectomy had to be performed. The patient was urgently relisted on the transplant list and after a few days was retransplanted.
| Case 2
A 1-year-old boy with Alagille's syndrome in stable condition preoperatively who received a left lateral segment from a split liver. During surgery, both arterial circulation and portal venous circulation were normal; however, no bile production was seen during surgery which was a concern. The first postoperative period was relatively uncomplicated, and routinely performed US examinations including a CEUS on the third postoperative day were all normal. Clinically the patient deteriorated and a HAT was suspected. Therefore, an urgent CEUS examination was requested. On the 5th postoperative day, the CEUS reported that there was no hepatic arterial circula- confirmed. However, no thrombosis was found. Six hours later, a hepatectomy had to be performed due to complete graft failure, and the patient was listed for urgent re-transplantation.
| Case 4
A 7-month-old girl with BA in stable condition preoperatively who Consequentially, the liver had to be extracted. The patient was urgently re-listed on the transplant list.
| Case 5
A 
| Case 6
An 8-month-old boy with Alfa-1-antitrypsin deficiency in stable condition preoperatively who received a left lateral segment from a split liver. During surgery, no biliary production was seen but no other complication occurred. The postoperative period was complicated. On the 9th postoperative day, the patient underwent surgery due to a bile leak. On the 11th postoperative day, a CEUS reported that there was no intrahepatic arterial circulation. Additionally, the report said that there was a large fluid accumulation adjacent to the liver.
TA B L E 2 Cause for transplantation in relation to transplantation technique and in relation to confirmed vascular complications within 30 d from surgery
The patient went to surgery that same day to explore the reason for the fluid accumulation. No additional bile leak was found, and serous fluid was removed. Oddly enough, no mention of the circulatory status of the liver graft could be found in the hospital charts and no additional examinations were performed to visualize the arterial circulation. Three days later, a non-contrast US was performed and no circulatory issue could be found. The patient did not need any further surgery after this. The case was considered a false positive.
| Positive and NPV
For diagnosing arterial circulatory complications, the PPV was 80%, with one false positive result and four true positive results. For diagnosing portal vein circulatory complications, the PPV was 66.7%
with one false positive and two true positives. For diagnosing any arterial or portal vein circulatory issue, the PPV was 75%. CEUS examinations that found perfusion issues only and no other circulatory pathology were not perceived as serious enough, and no specific action to correct the finding was deemed necessary from the transplantation surgeons.
The NPV was 100% and no patients without arterial or portal vein circulatory issue on CEUS needed surgery within the first 30 days after transplantation.
As showed in Table 3 , in 28% of the examinations the radiologist could not visualize the normal arterial blood flow without CEUS.
| D ISCUSS I ON
Clearly and accurately visualizing flow or absence thereof, in arteries as thin as 2 mm in diameter can be very challenging. However, it is extremely important, especially in the immediate postoperative setting, and the physician in charge of the examination needs all the help she/he can get. If this help comes in a safe, reliable and fast package it is even better. In our experience CEUS fits this description perfectly.
Our study was done with the aim of adding to the growing knowledge regarding the relatively rare pediatric use of CEUS in liver transplantation.
The most common vascular complications after OLT's are HAT and PVT. HAT is reported to complicate 0%-19% of OLTs and is generally more frequent after pediatric liver transplantation than after adult transplantation 1,2,17-20 PVT complicates 2%-17% of OLTs and this complication too is seen more frequently in the pediatric population. 1, 2, 17, 19 Our results suggest a complication rate that is in accordance with these other studies. However, it must be noted that we only have data on patients who performed a CEUS post-transplantation, meaning that a potentially significant portion of transplantations is not included in our numbers.
In general, the use of CEUS for post-liver transplantation evaluation is documented in a number of original studies and reviews on adult patients. For instance, in one prospective study published in 2006, 4 sensitivity, specificity, and diagnostic accuracy for correctly identifying vascular complications following liver transplantation were 91.3%, 100%, and 91.5%, respectively for Doppler US alone.
When performing a CEUS-sensitivity, specificity, and accuracy were all 100%.
Other studies showed that PPV and NPV ranged between 77%-92.9% and 99%-100% respectively for hepatic artery complications. 6, 7 No studies presenting equivalent results for portal vein complications are available. The notion that CEUS is useful in diagnosing vascular complications following liver transplants is in concordance with several other studies where CEUS is shown to surpass conventional US in that regard. 6, 8, [21] [22] [23] [24] [25] As mentioned above, none of the aforementioned studies were performed specifically on pediatric patients. However, the European federation of societies for ultrasound in medicine and biology 4, 40 This is very important in pediatric radiology, where examination times and patient compliance are directly correlated. A single center study 40 suggested that, aside from being safe and accurate, CEUS avoided a great number of CT and/or MRI examinations thus saving the institution money and resources, as well as avoiding the risks associated with above mentioned examinations.
The strengths of our study are that we present a relatively large number of patients and that we have detailed information regarding the graft and the recipient through our electronic patient chart. All transplants and postoperative care, as well as follow-up of these patients take place in our institution. The limitations of our study, on the other hand, are mainly concerned with the retrospective nature of our study. We have no control of the documentation and no possibility to standardize the examination and reporting.
Our data suggest CEUS to be an efficient, accurate, and safe diagnostic method for detecting postoperative vascular complications after liver transplantation in the pediatric population. We especially see its potential use as a "problem solver," and a viable alternative to other diagnostic methods in inconclusive or difficult cases.
In conclusion, concerted efforts are needed to achieve official licensing in order to facilitate the use of pediatric CEUS.
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